Effects of Astragaloside IV on the SDF-1/CXCR4 Expression in Atherosclerosis of apoE−/−Mice Induced by Hyperlipaemia

A ROS-mediated lysosomal–mitochondrial pathway is induced by a novel Amonafide analogue, 7c, in human Hela cervix carcinoma cells

(2013) Ke Shen et al.   CANCER LETTERS

The CD40/CD40L system: A new therapeutic target for disease

(2013) Bikui Zhang et al.   IMMUNOLOGY LETTERS

Bone Marrow Endothelial Progenitors Augment Atherosclerotic Plaque Regression in a Mouse Model of Plasma Lipid Lowering

(2012) Longbiao Yao et al.   STEM CELLS

Astragaloside IV Stimulates Angiogenesis and Increases Hypoxia-Inducible Factor-1  Accumulation via Phosphatidylinositol 3-Kinase/Akt Pathway

(2011) L. Zhang et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

CXCR4 expression correlates with the degree of tumor infiltration and BRAF status in papillary thyroid carcinomas

(2011) Liborio Torregrossa et al.   MODERN PATHOLOGY

Pro-angiogenic activity of astragaloside IV in HUVECs in vitro and zebrafish in vivo

(2011) Simon Lee   Molecular Medicine Reports

The Hemostatic System as a Modulator of Atherosclerosis

(2011) Julian Ilcheff Borissoff et al.   NEW ENGLAND JOURNAL OF MEDICINE

Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis

(2010) D. Lievens et al.   BLOOD

Platelet Aggregates-Induced Human CD34+Progenitor Cell Proliferation and Differentiation to Macrophages and Foam Cells Is Mediated by Stromal Cell Derived Factor 1 in Vitro

(2010) Konstantinos Stellos et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS